Bharat Biotech’s Covaxin Now in Oman’s List of Approved Covid-19 Vaccines

This will significantly ease travel to Oman for Indian nationals who have taken Covaxin. (Image: AP/File)

The vaccine major cited a press release issued by the Embassy of India, Muscat, in this regard.

  • PTI New Delhi
  • Last Updated:October 28, 2021, 16:14 IST
  • FOLLOW US ON:

Bharat Biotech’s Covaxin has been included to the approved list of Covid-19 vaccines for travel to Oman without quarantine. In a tweet, Bharat Biotech noted: “Covaxin has now been added to the approved list of #COVID19 vaccines for travel to Oman without quarantine. This will facilitate travelers from India vaccinated with Covaxin.” The vaccine major cited a press release issued by the Embassy of India, Muscat, in this regard.

“Embassy of India, Muscat, is pleased to inform that the Government of the Sultanate of Oman has added Covaxin to the approved list of Covid-19 vaccines for travel to Oman. The Civil Aviation Authority issued a notification on 27 October regarding this,” the release stated. All passengers from India who have received two doses of Covaxin at-least 14 days before the estimated arrival date will now be able to travel to Oman without the requirement of quarantine, it added.

All other Covid-19 related requirements/conditions, such as pre-arrival RT-PCR test shall be applicable for such passengers, the release stated. This notification will significantly ease travel to Oman for Indian nationals who have taken Covaxin, it noted.

Passengers who have taken AstraZeneca/Covishield are already permitted to travel to Oman without quarantine.

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.

For all the latest business News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.